modified PASI
Showing 1 - 25 of 4,777
Psoriasis, Skin Diseases Trial in Worldwide (Orismilast modified release tablets, Placebo)
Recruiting
- Psoriasis
- Skin Diseases
- Orismilast modified release tablets
- Placebo
-
Cromwell, Connecticut
- +33 more
Dec 30, 2021
Psoriasis Trial in Winston-Salem (Text reminder)
Not yet recruiting
- Psoriasis
- Text reminder
-
Winston-Salem, North CarolinaWake Forest University Health Sciences Department of Dermatology
Jan 31, 2023
Arthritis, Psoriatic Trial in Worldwide (Guselkumab, Placebo)
Moderate-to-severe Plaque Psoriasis Patients Response to
Completed
- Moderate-to-severe Plaque Psoriasis
-
Jakarta, IndonesiaMangga Besar Clinic
Mar 15, 2023
Psoriasis Trial in Olsztyn (Chicory-derived inulin-type ß-fructans, Maltodextrin)
Enrolling by invitation
- Psoriasis
- Chicory-derived inulin-type β-fructans
- Maltodextrin
-
Olsztyn, Poland
- +1 more
Jul 24, 2023
Moderate-to-Severe Plaque Psoriasis Trial in Shenyang (Jaktinib, Placebo)
Recruiting
- Moderate-to-Severe Plaque Psoriasis
- Jaktinib
- Placebo
-
Shenyang, Liaoning, ChinaThe First Affiliated Hospital of China Medical University
Nov 28, 2022
Down Syndrome, Alopecia Areata, Atopic Dermatitis / Eczema Trial in Aurora (Tofacitinib)
Recruiting
- Down Syndrome
- +5 more
-
Aurora, ColoradoLinda Crnic Institute for Down Syndrome
Jan 17, 2023
Psoriasis, Psoriasis Vulgaris, Psychophysiological Disorder Trial in San Diego (HRV-Biofeedback/Mind-Body Therapy)
Recruiting
- Psoriasis
- +9 more
- HRV-Biofeedback/Mind-Body Therapy
-
San Diego, CaliforniaBastyr University Clinic
Aug 16, 2022
ImmuNe-Mediated Inflammatory Diseases Trial in Milan (Questionnaires)
Not yet recruiting
- ImmuNe-Mediated Inflammatory Diseases
- Questionnaires
-
Milan, ItalyIRCCS Istituto Ortopedico Galeazzi
Jan 10, 2022
Psoriatic Arthritis Trial in Frankfurt am Main (Methotrexate, Ustekinumab, Placebo)
Completed
- Psoriatic Arthritis
- Methotrexate
- +2 more
-
Frankfurt am Main, Hessia, GermanyCIRI
Mar 1, 2022
Pustular Psoriasis (PP) Trial in Italy, Singapore, Switzerland (biological sampling, Phenotypic description, Photography)
Recruiting
- Pustular Psoriasis (PP)
- biological sampling
- +2 more
-
Rome, Italy
- +3 more
Jul 5, 2022
Psoriasis Trial (Secukinumab 300 mg, Placebo)
Withdrawn
- Psoriasis
- Secukinumab 300 mg
- Placebo
- (no location specified)
Jan 30, 2022
Modifiable Stroke Risk Factors in Covert Brain Infarctions
Recruiting
- Silent Stroke
- +5 more
-
Tours, France
- +1 more
Jan 6, 2023
Plaque Psoriasis Trial in Budapest, Hévíz (balneotherapy)
Recruiting
- Plaque Psoriasis
- balneotherapy
-
Budapest, Hungary
- +1 more
Jun 22, 2022
Bruxism Trial in Dokki (Laser acupuncture, Modified physical therapy)
Completed
- Bruxism
- Laser acupuncture
- Modified physical therapy
-
Dokki, Giza, EgyptNational Research Centre
Nov 12, 2023